A combination of Merck’s…
A combination of Merck’s islatravir and Gilead’s lenacapavir has succeeded [...]
Mere months after obesity biotech…
Mere months after obesity biotech Kailera Therapeutics netted the biggest [...]
Eli Lilly has signed a heavily…
Eli Lilly has signed a heavily backloaded agreement to license [...]
With a pair of phase 2 readouts,…
With a pair of phase 2 readouts, AstraZeneca is positioning [...]
Medical Advances Are Keeping a Health Reporter Busy
A conversation with Gina Kolata, who covers breakthroughs in medical [...]
Looking to spark an antibody-like…
Looking to spark an antibody-like revolution for RNA interference medicines, [...]
With an obesity green light…
With an obesity green light already in hand, Eli Lilly [...]
Eli Lilly emerged as the “clear…
Eli Lilly emerged as the “clear winner from ADA,” according [...]
Actress Mariska Hargitay looks…
Actress Mariska Hargitay looks back on her late father’s multiple [...]
For Novo Nordisk, the launch of…
For Novo Nordisk, the launch of the company’s highly anticipated [...]